Search results
Communication aid technology 'opens doors' for patients
BBC News· 7 days agoA clinician who works with people living with conditions such as motor neurone disease (MND) and...
Is Charter Communications, Inc. (CHTR) the Worst Communication Services Stock to Buy According to...
Insider Monkey via Yahoo Finance UK· 2 days agoWe recently compiled a list of the 10 Worst Communication Services Stocks to Buy According to Short...
Haier's AI Evolution: Charting The Course For GE Appliances
Forbes· 16 hours agoGE Appliances is one of the Most Innovative Companies by Fast Company. Haier's strategy offers...
A Psychologist Explains ‘Phantom Vibration Syndrome’—Smartphone Hallucinations
Forbes· 2 days agoCommunication has never been easier, and information has never been more accessible. From doomscrolling and nomophobia to notification overload and digital fatigue, it’s certainly ...
Q2 Earnings Highlights: Micron Technology (NASDAQ:MU) Vs The Rest Of The Semiconductors Stocks
StockStory via Yahoo Finance UK· 3 days agoEarnings results often indicate what direction a company will take in the months ahead. With Q2...
New brain-on-a-chip platform to deliver 460x efficiency boost for AI tasks
Network World· 2 days agoThe Indian Institute of Science (IISc) has announced a breakthrough in artificial intelligence...
I was expelled aged 11 & fell into gangs - now I'm snaring them, says SAS star
The Sun· 5 days ago“Put your phones down, put your laptops down. Don’t get involved in social media, keep a low profile...
Human neural stem cell-derived artificial organelles to improve oxidative phosphorylation - Nature ...
Nature· 7 days agoRegulating oxidative phosphorylation and restoring redox homeostasis are crucial in neurological disorders. Here, the authors develop a top-down membrane self-assembly strategy to develop stem ...
Elon Musk Could Soon Become a Trillionaire: What’s His Next Move?
GOBankingRates via Yahoo Finance UK· 1 day agoIf you think billionaires are wealthy beyond imagination, try to wrap your head around the concept...
CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma
PharmiWeb· 2 days agoTÜBINGEN, Germany/BOSTON, USA – September 13, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ...